Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb;102(2):115576.
doi: 10.1016/j.diagmicrobio.2021.115576. Epub 2021 Oct 22.

Frequency of respiratory pathogens other than SARS-CoV-2 detected during COVID-19 testing

Affiliations

Frequency of respiratory pathogens other than SARS-CoV-2 detected during COVID-19 testing

Matheus Negri Boschiero et al. Diagn Microbiol Infect Dis. 2022 Feb.

Abstract

The frequencies of 19 respiratory pathogens other than SARS-CoV-2 were assessed in 6,"?>235 Brazilian individuals tested for COVID-19. Overall, only 83 individuals who tested positive for SARS-CoV-2 had codetection of other pathogens. Individuals infected with Rhinovirus/Enterovirus, Human Coronavirus (HCoV)-HKU1, HCoV-NL63, HPIV-4, Influenza A (-H1N1 and other subtypes), Influenza B, Human Respiratory Syncytial Virus and Human Metapneumovirus were less likely to test positive for SARS-CoV-2. Infection with Streptococcys pyogenes, Chlamydophila pneumoniae, Mycoplasma pneumoniae, and Bordetella pertussis were more frequent in individuals who tested negative for SARS-CoV-2, but without significancy. We found 150 individuals infected with ≥2 pathogens other than SARS-CoV-2, only 3 out of whom tested positive for COVID-19. The codetection frequency was low in individuals diagnosed with COVID-19. Other viral infections may provide a cross-reactive, protective immune response against SARS-CoV-2. Screening for bacterial respiratory infections upon COVID-19 testing is important to drive suitable therapeutic approaches and avoid unnecessary antibiotic prescription.

Keywords: COVID-19; Codetection; Pandemic; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The authors report no conflicts of interest relevant to this article.

Figures

Fig 1
Fig. 1
Database management and statistical analysis protocol.
Fig 2
Fig. 2
Prevalence of different micro-organisms in individuals included in our cohort according to the COVID-19 status. In the graphic on the left, each bar represents the frequency of individuals who tested positive for the corresponding micro-organism. In the graphic on the right, the dots represent the odds ratio (OR) values for testing positive for COVID-19, and the extremities of each line represent the upper and lower limits of the 95% confidence interval. *, represents the pathogens with significative difference between the patients distributed by COVID-19 status – P-value <0.05.

References

    1. Abdella R, Aggarwal M, Okura T, Lamb RA, He Y. Structure of a paramyxovirus polymerase complex reveals a unique methyltransferase-CTD conformation. Proc Natl Acad Sci U S A. 2020;117:4931–4941. - PMC - PubMed
    1. Aragon TJ, Fay MP, Wollschlaeger D, Omidpanah A. epitools: epidemiology Tools. (2020).
    1. Aran D, Beachler DC, Lanes S, Overhage JM. Prior presumed coronavirus infection reduces COVID-19 risk: a cohort study. J Infect. 2020;81:923–930. - PMC - PubMed
    1. Berthold MR, Cebron N, Dill F, Gabriel TR, Kotter T, Meinl T, et al. In: Data analysis, machine learning and applications. Preisach C, Burkhardt H, Schmidt-Thieme L, Decker R, editors. Springer; 2008. KNIME: The Konstanz Information Miner; pp. 319–326. - DOI
    1. Bishburg E, Okoh A, Nagarakanti SR, Lindner M, Migliore C, Patel P. Fungemia in COVID-19 ICU patients, a single medical center experience. J Med Virol. 2021;93:2810–2814. - PubMed